✨ Free AI Report
180 Life Sciences Corp.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview 180 Life Sciences Corp.
Research Preview

180 Life Sciences Corp.: Business Overview, Financials & Competitive Analysis

180 Life Sciences began as a biotechnology company and pivoted toward iGaming, then further evolved by adopting an Ethereum treasury strategy and rebranding to operate as ETHZilla, developing an accumulation vehicle f...

Analyst-debate audio for 180 Life Sciences Corp.

AskCyborg analysts argue the bull and bear cases for 180 Life Sciences Corp. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
180 Life Sciences Corp. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
5/ 10Mixed

Cyborg Score thesis

Crypto-focused treasury company with material ETH holdings but dependent on speculative digital asset valuations and execution of...

Read the full analyst-debate transcript →
Industry Cryptocurrency Treasury/Digital Asset Accumulation & Legacy Biotechnology IP
2 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 2, 2026
AI-Generated Research
30+ Page Report

Get the Latest 180 Life Sciences Corp. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

180 Life Sciences Corp. Overview

Pro stress-test →

180 Life Sciences began as a biotechnology company and pivoted toward iGaming, then further evolved by adopting an Ethereum treasury strategy and rebranding to operate as ETHZilla, developing an accumulation vehicle for Ether (ETH). Through a treasury policy focused on ETH, it aims to hold Ether as the principal asset in its treasury reserve.

Strategic Profile

Pro stress-test →

The company closed a $425 million private placement and raised $565 million total through private placements and convertible notes to implement its Ethereum treasury strategy. It has accumulated 94,675 ETH valued at approximately $419 million with $187 million in cash, with Electric Capital serving as external asset manager implementing an on-chain yield generation program.

Competitive Landscape

Pro stress-test →

Other biotech companies have shifted toward becoming crypto treasury companies, this time focusing on Ethereum. The company competes against traditional cryptocurrency investment vehicles and ETH staking platforms. Legacy biotech IP represents niche positioning in neuroinflammation and fibrotic disorder therapeutics.

Industry Context

180 Life Sciences Corp. operates in Cryptocurrency Treasury/Digital Asset Accumulation & Legacy Biotechnology IP.

Key facts

Founded: Prior as 180 Life Sciences biotech; rebranded 2025 as ETHZilla · Headquarters: Palo Alto, California · Employees: Not available · Revenue: Not disclosed for crypto operations · Market cap: ~$1.1B (October 2025 data)

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on 180 Life Sciences Corp..

+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when 180 Life Sciences Corp. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Ethereum Staking/Treasury ManagementProfessional yield generation through staking and DeFi protocols→Traditional Biotech Drug DevelopmentCNS and fibrosis therapeutic development (historical positioning)→

Compare 180 Life Sciences Corp. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

180 Life Sciences Corp. operates in Cryptocurrency Treasury/Digital Asset Accumulation & Legacy Biotechnology IP. See how the rest of the sector scores on the Cyborg framework.

Browse Cryptocurrency Treasury/Digital Asset Accumulation & Legacy Biotechnology IP research →
NEW · MCP server

Ask your AI assistant about 180 Life Sciences Corp.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare 180 Life Sciences Corp. and its top competitor on Cyborg Score”
“What did 180 Life Sciences Corp. do this quarter?”
“Is 180 Life Sciences Corp. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does 180 Life Sciences Corp. do?+
180 Life Sciences began as a biotechnology company and pivoted toward iGaming, then further evolved by adopting an Ethereum treasury strategy and rebranding to operate as ETHZilla, developing an accumulation vehicle f...
What is 180 Life Sciences Corp.'s Cyborg Score?+
180 Life Sciences Corp. has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are 180 Life Sciences Corp.'s main competitors?+
Named competitors include Ethereum Staking/Treasury Management, Traditional Biotech Drug Development. The full competitive landscape is in the AskCyborg report.
How can I get the full 180 Life Sciences Corp. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the 180 Life Sciences Corp. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track 180 Life Sciences Corp. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.